| Literature DB >> 18223356 |
Soley Seren1, Ronald Lieberman, Ulas D Bayraktar, Elisabeth Heath, Kazim Sahin, Fundagul Andic, Omer Kucuk.
Abstract
Dietary intake of lycopene is inversely associated with the risk of many cancers. Preclinical studies show that lycopene has potent in vitro and in vivo antitumor effects, suggesting potential preventive and therapeutic roles for the compound. However, clinical trials with lycopene have only recently been started, and available clinical data preclude firm conclusions with regard to its use in cancer prevention and treatment. Further mechanistic studies and randomized controlled clinical intervention trials with lycopene involving cancer patients are warranted.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18223356 DOI: 10.1097/MJT.0b013e31804c7120
Source DB: PubMed Journal: Am J Ther ISSN: 1075-2765 Impact factor: 2.688